Immune Response News and Research

RSS

Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine.

14 Sep 2016

Steroids for treating infertility in women may have harmful effects on pregnancy and child

Researchers at the University of Adelaide are urging doctors and patients to refrain from using a specific steroid treatment to treat infertility in women unless clinically indicated, because of its links to miscarriage, preterm birth and birth defects.

9 Sep 2016

Trial of high-dose flu vaccine aims to better protect heart failure patients

A network of researchers in the United States and Canada will try to spare thousands of patients the dangers of heart attacks and hospitalizations over the next five years in a trial of a high-dose flu vaccine.

8 Sep 2016

Stealth insulin-producing pig cells may offer solution for treating Type 1 diabetes in humans

University of Alabama at Birmingham researchers are exploring ways to wrap pig tissue with a protective coating to ultimately fight diabetes in humans. The nano-thin bilayers of protective material are meant to deter or prevent immune rejection.

8 Sep 2016

New blood test helps identify bacterial infection in infants with fever

A blood test used to measure patterns of ribonucleic acid (RNA) expression can help determine if fever in infants under 2 months old is caused by bacterial or viral infection, according to a preliminary study recently published in the Journal of the American Medical Association.

8 Sep 2016

Researchers discover second line of defense in macaques co-infected with Mtb and SIV

Tulane University researchers found some monkeys whose immune systems are depleted by the simian strain of HIV have a second line of defense against tuberculosis.

7 Sep 2016

Enzyme from oral bacteria could be potential therapy for celiac disease

Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease (CD), an autoimmune disorder that causes severe digestive and other health problems among sufferers when they consume gluten.

6 Sep 2016

New discovery offers way to develop vaccine against highly infectious bacteria

Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria--responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or "flesh-eating disease."

5 Sep 2016

Gut bacteria may play role in immune recovery of HIV patients

An international study coordinated by Spanish research institutes has found that gut bacteria also play their role in the immune recovery of HIV patients.

5 Sep 2016

New discovery could potentially lead to treatments for Crohn's disease

Scientists at the University of British Columbia have made a discovery that could potentially lead to treatments for a debilitating complication of Crohn's disease.

2 Sep 2016

Moderation and appropriate rest periods may be key to healthier CrossFit workouts

Are you a fitness enthusiast? If so, moderation and appropriate rest periods may be the key to healthier exercise, as consecutive CrossFit-style workouts could impair the immune system by affecting inflammatory proteins.

1 Sep 2016

Researchers discover protein that plays role in onset of type 1 diabetes

A new study reveals a counterintuitive cellular strategy that may protect insulin-producing cells from destruction during type 1 diabetes.

31 Aug 2016

Leading Chikungunya vaccine in clinical trial phase 2

With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.

29 Aug 2016

Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

The Oswaldo Cruz Foundation at Rio de Janeiro, Brazil, will start the phase II clinical trials of a vaccine for schistosomiasis, called 'Sm14 Vaccine'.

26 Aug 2016

Research findings pave way to effective strategies for treatment of visceral leishmaniasis

A study shows that stimulating the production of interleukin-17A (IL-17A), one of the cytokines released by cells of the immune system, can be an effective strategy for the treatment of visceral leishmaniasis, considered one of the six most important parasitic diseases affecting humans.

25 Aug 2016

Immune Response News and Research

Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

Steroids for treating infertility in women may have harmful effects on pregnancy and child

Trial of high-dose flu vaccine aims to better protect heart failure patients

Stealth insulin-producing pig cells may offer solution for treating Type 1 diabetes in humans

New blood test helps identify bacterial infection in infants with fever

Researchers discover second line of defense in macaques co-infected with Mtb and SIV

Enzyme from oral bacteria could be potential therapy for celiac disease

New discovery offers way to develop vaccine against highly infectious bacteria

Gut bacteria may play role in immune recovery of HIV patients

New discovery could potentially lead to treatments for Crohn's disease

Moderation and appropriate rest periods may be key to healthier CrossFit workouts

Researchers discover protein that plays role in onset of type 1 diabetes

Leading Chikungunya vaccine in clinical trial phase 2

Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

Research findings pave way to effective strategies for treatment of visceral leishmaniasis

NIBIB researchers develop nanovaccine to enhance cancer immunotherapy

Research findings could lead to new ways of preventing or treating organ transplant rejection

New drug target could help prevent opioid tolerance and addiction

Sick animals disconnect from social groups leading to decrease in disease transmission, study shows

NYIT researcher aims to study link between wound healing problems and methamphetamine use

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News